o
|
this post-effective amendment designates a new effective date for a previously filed post-effective amendment.
|
|
_____________________________________________________________________________________________
|
|
DECLARATION REQUIRED BY RULE 24f-2 (a) (1)
|
Page | |
FUND SUMMARY | 1 |
INVESTMENTS, RISKS, AND PERFORMANCE | 2 |
MANAGEMENT | 5 |
MIDAS FUND | 7 |
INVESTMENTS, RISKS, AND PERFORMANCE | 7 |
MANAGEMENT | 11 |
MIDAS MAGIC | 12 |
INVESTMENTS, RISKS, AND PERFORMANCE | 12 |
MANAGEMENT | 15 |
TAX INFORMATION
|
16 |
PAYMENTS TO BROKER-DEALERS AND OTHER FINANCIAL INTERMEDIARIES | 16 |
INVESTMENT OBJECTIVES, PRINCIPAL INVESTMENT STRATEGIES, RELATED RISKS, AND DISCLOSURE OF PORTFOLIO HOLDINGS
|
16 |
ADDITIONAL INVESTMENT RISKS | 23 |
PORTFOLIO MANAGEMENT | 23 |
MANAGEMENT FEES | 23 |
DISTRIBUTION AND SHAREHOLDER SERVICES
|
24 |
PURCHASING SHARES | 24 |
EXCHANGE PRIVILEGES | 26 |
REDEEMING SHARES | 26 |
ACCOUNT AND TRANSACTION POLICIES | 27 |
DISTRIBUTIONS AND TAXES | 28 |
FINANCIAL HIGHLIGHTS | 30 |
Maximum Sales Charge (Load) Imposed on Purchases
|
NONE
|
Maximum Deferred Sales Charge (Load)
|
NONE
|
Maximum Sales Charge (Load) Imposed on Reinvested Dividends
|
NONE
|
Redemption Fee on shares redeemed within 30 days of purchase
|
1.00%
|
Management Fees
|
0.50 | % | ||
Distribution and Service (12b-1) Fees
|
0.25 | % | ||
Other Expenses
|
1.10 | % | ||
Acquired Fund Fees and Expenses
|
0.10 | % | ||
Total Annual Fund Operating Expenses
1
|
1.95 | % | ||
Fee Waiver
2
|
0.50 | % | ||
Total Annual Fund Operating Expenses After Fee Waiver
|
1.45 | % |
One Year
|
Three Years
|
Five Years
|
Ten Years
|
|||||||||||
$
|
148
|
$
|
564
|
$
|
1,006
|
$
|
2,234
|
|
Best Quarter:
7/1/09 - 9/30/09
7.69%
Worst Quarter:
7/1/11 - 9/30/11
(3.10)%
|
1 Year
|
5 Years
|
10 Years
|
||||||||||
Return Before Taxes
|
0.96 | % | 7.05 | % | 4.15 | % | ||||||
Return After Taxes on Distributions
|
(0.24 | )% | 6.36 | % | 3.57 | % | ||||||
Return After Taxes on Distributions and Sale of Fund Shares
|
1.94 | % | 5.82 | % | 3.30 | % | ||||||
S&P 500 Index (reflects no deduction for fees, expenses, or taxes)
|
2.11 | % | (0.25 | )% | 2.92 | % | ||||||
LMTACFI
|
2.53 | % | 3.69 | % | 4.37 | % | ||||||
LMATAMI
|
0.37 | % | 1.40 | % | 4.06 | % |
Maximum Sales Charge (Load) Imposed on Purchases
|
NONE
|
Maximum Deferred Sales Charge (Load)
|
NONE
|
Maximum Sales Charge (Load) Imposed on Reinvested Dividends
|
NONE
|
Redemption Fee on shares redeemed within 30 days of purchase
|
1.00%
|
Management Fees
|
1.00 | % | ||
Distribution and Service (12b-1) Fees
|
0.25 | % | ||
Other Expenses
|
1.06 | % | ||
Total Annual Fund Operating Expenses
|
2.31 | % |
One Year
|
Three Years
|
Five Years
|
Ten Years
|
|||||||||||
$
|
234
|
$
|
721
|
$
|
1,235
|
$
|
2,646
|
|
Best Quarter:
1/1/02 - 3/31/02
32.63%
Worst Quarter:
7/1/08 - 9/30/08
(41.51)%
|
1 Year
|
5 Years
|
10 Years
|
||||||||||
Return Before Taxes
|
(35.97 | )% | (2.15 | )% | 15.06 | % | ||||||
Return After Taxes on Distributions
|
(36.27 | )% | (2.65 | )% | 14.75 | % | ||||||
Return After Taxes on Distributions and Sale of Fund Shares
|
(23.33 | )% | (2.12 | )% | 13.47 | % | ||||||
S&P 500 Index (reflects no deduction for fees, expenses, or taxes)
|
2.11 | % | (0.25 | )% | 2.92 | % | ||||||
PMA (reflects no deduction for fees, expenses, or taxes)
|
(20.68 | )% | 7.91 | % | 20.10 | % |
Maximum Sales Charge (Load) Imposed on Purchases
|
NONE
|
Maximum Deferred Sales Charge (Load)
|
NONE
|
Maximum Sales Charge (Load) Imposed on Reinvested Dividends
|
NONE
|
Redemption Fee on shares redeemed within 30 days of purchase
|
1.00%
|
Management Fees
|
0.99 | % | ||
Distribution and Service (12b-1) Fees
|
1.00 | % | ||
Other Expenses
|
2.17 | % | ||
Total Annual Fund Operating Expenses
|
4.16 | % |
One Year
|
Three Years
|
Five Years
|
Ten Years
|
|||||||||||
$
|
418
|
$
|
1,264
|
$
|
2,124
|
$
|
4,339
|
|
Best Quarter:
7/1/09 - 9/30/09
23.28%
Worst Quarter:
10/1/08 - 12/31/08
(32.60)%
|
1 Year
|
5 Years
|
10 Years
|
||||||||||
Return Before Taxes
|
8.62 | % | (0.90 | )% | 1.02 | % | ||||||
Return After Taxes on Distributions
|
8.62 | % | (0.90 | )% | 1.02 | % | ||||||
Return After Taxes on Distributions and Sale of Fund Shares
|
5.60 | % | (0.76 | )% | 0.88 | % | ||||||
S&P 500 Index (reflects no deduction for fees, expenses, or taxes)
|
2.11 | % | (0.25 | )% | 2.92 | % | ||||||
Russell 2000 Index (reflects no deduction for fees, expenses, or taxes)
|
(4.18 | )% | 0.15 | % | 5.62 | % |
Account Type
|
Initial
|
Subsequent
|
IRAs and HSAs
|
Initial
|
Subsequent
|
Regular
|
$100
|
Traditional, Roth IRA, HSA
|
$1,000
|
$100
|
|
UGMA/UTMA
|
$1,000
|
$100
|
Spousal, Rollover IRA
|
$1,000
|
$100
|
Education Savings Account
|
$1,000
|
$100
|
SEP, SAR-SEP, SIMPLE IRA
|
$1,000
|
$100
|
Automatic Investment Program
|
$100
|
$100
|
Health Savings Account
|
$1,000
|
$100
|
Investment Category
|
Target Percentage
|
|||
Gold
|
20 | % | ||
Silver
|
10 | % | ||
Swiss Franc Assets
|
20 | % | ||
Hard Asset Securities
|
25 | % | ||
Large Capitalization Growth Stocks
|
25 | % | ||
Total
|
100 | % |
Target Percentage with Leverage
|
||||||||
Investment Category
|
As an Approximate Percent of Net Assets
|
As an Approximate Percent of Total Assets
|
||||||
Gold
|
20 | % | 16 | % | ||||
Silver
|
10 | % | 8 | % | ||||
Swiss Franc Assets
|
20 | % | 16 | % | ||||
Hard Asset Securities
|
25 | % | 20 | % | ||||
Large Capitalization Growth Stocks
|
50 | % | 40 | % | ||||
Total
|
125 | % | 100 | % |
Plan
|
Description
|
Midas Bank Transfer Plan
|
For making automatic investments from a designated bank account.
|
Midas Salary Investing Plan
|
For making automatic investments through a payroll deduction.
|
Midas Government Direct Deposit Plan
|
For making automatic investments from your federal employment, Social Security, or other regular federal government check.
|
Transaction
|
Tax treatment
|
Income dividend
|
Ordinary income or qualified dividend income
|
Net short term capital gain distribution
|
Ordinary income |
Net long term capital gain distribution
|
Long term capital gain
|
Sale or exchange of shares held for more than one year
|
Long term capital gain or loss
|
Sale or exchange of shares held for one year or less
|
Gains that are not offset by capital losses are treated as ordinary income; net losses are subject to special rules
|
MIDAS PERPETUAL PORTFOLIO
|
||||||||||||||||||||||||
Six Months Ended
June 30,
|
For the Year Ended December 31,
|
|||||||||||||||||||||||
2012
|
2011
|
2010
|
2009 | 1 | 2008 | 1 | 2007 | 1 | ||||||||||||||||
Per Share Data (for a share outstanding throughout each period)
|
||||||||||||||||||||||||
Net asset value, beginning of period
|
$ | 1.22 | $ | 1.30 | $ | 1.15 | $ | 1.00 | $ | 1.000 | $ | 1.000 | ||||||||||||
Income (loss) from investment operations:
|
||||||||||||||||||||||||
Net investment income (loss)
(2)
|
- | (0.01 | ) | (0.01 | ) | (0.01 | ) | 0.012 | 0.039 | |||||||||||||||
Net realized and unrealized gain on investments
|
$ | 0.02 | $ | 0.02 | $ | 0.16 | $ | 0.18 | - | - | ||||||||||||||
Total from investment operations
|
$ | 0.02 | 0.01 | 0.15 | 0.17 | - | - | |||||||||||||||||
Less distributions:
|
||||||||||||||||||||||||
Net investment income
|
- | (0.01 | ) | - | - | (0.012 | ) | (0.039 | ) | |||||||||||||||
Realized gains
|
- | (0.08 | ) | - | (0.02 | ) | - | - | ||||||||||||||||
Total distributions
|
- | (0.09 | ) | - | (0.02 | ) | (0.012 | ) | (0.039 | ) | ||||||||||||||
Net asset value, end of period
|
$ | 1.24 | $ | 1.22 | $ | 1.30 | $ | 1.15 | $ | 1.000 | $ | 1.000 | ||||||||||||
Total Return
(3)
|
1.64 | % | 0.96 | % | 13.04 | % | 17.03 | % | 1.22 | % | 4.00 | % | ||||||||||||
Ratios/Supplemental Data
|
||||||||||||||||||||||||
Net assets at end of period (000s omitted)
|
$ | 15,853 | $ | 15,459 | $ | 10,620 | $ | 8,311 | $ | 7,191 | $ | 14,516 | ||||||||||||
Ratio of total expenses to average net assets
(4)
|
2.04 | %* | 1.85 | % | 2.51 | % | 2.98 | % | 1.77 | % | 1.91 | % | ||||||||||||
Ratio of net expenses to average net assets
(3) (5)
|
1.54 | %* | 1.35 | % | 1.93 | % | 2.23 | % | 1.21 | % | 1.16 | % | ||||||||||||
Ratio of net expenses excluding loan interest and fees to average net assets
|
1.54 | %* | 1.35 | % | 1.90 | % | 2.22 | % | - | - | ||||||||||||||
Ratio of net investment income (loss) to average net assets
(3)
|
(0.48 | )%* | (0.45 | )% | (1.03 | )% | (1.29 | )% | 1.22 | % | 3.92 | % | ||||||||||||
Portfolio turnover rate
|
0 | % | 44 | % | 4 | % | 24 | % | 0 | % | 0 | % |
(1)
|
These financial highlights reflect the Fund’s operation as a money market fund up to December 28, 2008. On December 29, 2008, the Fund changed its name to Midas Perpetual Portfolio, Inc. from Midas Dollar Reserves, Inc., ceased operating as a money market fund, and began operating as a fluctuating net asset value fund pursuant to its current investment objective and policies.
|
(2)
|
Average shares outstanding during the period are used to calculate per share data.
|
(3)
|
Fees contractually waived by the Investment Manager reduced the ratio of expenses to average net assets by 0.50% in each of the periods for the six months ended June 30, 2012 and the year ended December 31, 2011, and by the Investment Manager and Distributor by 0.58%, and 0.75% for the years ended December 31, 2010 and 2009, respectively. Fees voluntarily waived by the Investment Manager and Distributor reduced the ratio of net expenses to average net assets by 0.24% and 0.75% for the years ended December 31, 2008 and 2007, respectively. In addition, the Investment Manager voluntarily reimbursed the Fund for certain operating expenses which further reduced the ratio of net expenses to average net assets by 0.32%, for the year ended December 31, 2008. The impact of the fee waivers and reimbursements is reflected in both the total return and the ratio of net investment income (loss) to average net assets.
|
(4)
|
“Total expenses” are the expenses of the Fund as presented in the Statement of Operations before fee waivers.
|
(5)
|
“Net expenses” are the expenses of the Fund as presented in the Statement of Operations after fee waivers.
|
MIDAS FUND
|
||||||||||||||||||||||||
Six Months Ended June 30,
|
For the Year Ended December 31,
|
|||||||||||||||||||||||
2012
|
2011
|
2010
|
2009
|
2008
|
2007
|
|||||||||||||||||||
Per Share Data (for a share outstanding throughout each period)
|
||||||||||||||||||||||||
Net asset value, beginning of period
|
$ | 3.57 | $ | 5.65 | $ | 3.82 | $ | 2.11 | $ | 5.64 | $ | 4.29 | ||||||||||||
Income (loss) from investment operations:
|
||||||||||||||||||||||||
Net investment loss
(1)
|
(0.02 | ) | (0.06 | ) | (0.07 | ) | (0.05 | ) | (0.06 | ) | (0.08 | ) | ||||||||||||
Net realized and unrealized gain (loss) on investments
|
(1.20 | ) | (1.96 | ) | 1.90 | 1.80 | (3.36 | ) | 1.44 | |||||||||||||||
Total from investment operations
|
(1.22 | ) | (2.02 | ) | 1.83 | 1.75 | (3.42 | ) | 1.36 | |||||||||||||||
Less distributions:
|
||||||||||||||||||||||||
Net investment income
|
- | (0.06 | ) | - | (0.04 | ) | (0.11 | ) | (0.01 | ) | ||||||||||||||
Total distributions
|
- | (0.06 | ) | - | (0.04 | ) | (0.11 | ) | (0.01 | ) | ||||||||||||||
Net asset value, end of period
|
$ | 2.35 | $ | 3.57 | $ | 5.65 | $ | 3.82 | $ | 2.11 | $ | 5.64 | ||||||||||||
Total Return
|
(34.17 | ) % | (35.97 | ) % | 47.91 | % | 83.88 | % | (60.89 | ) % | 31.70 | % | ||||||||||||
Ratios/Supplemental Data
|
||||||||||||||||||||||||
Net assets at end of period (000s omitted)
|
$ | 44,298 | $ | 72,973 | $ | 139,644 | $ | 116,311 | $ | 77,502 | $ | 251,394 | ||||||||||||
Ratio of total expenses to average net assets
|
2.53 | %* | 2.31 | % | 2.29 | % | 2.39 | % | 2.37 | % | 2.43 | % | ||||||||||||
Ratio of net expenses to average net assets
|
2.53 | %* | 2.31 | % | 2.29 | % | 2.39 | % | 2.37 | % | 2.43 | % | ||||||||||||
Ratio of net expenses excluding loan interest and fees to average net assets
|
2.40 | %* | 2.16 | % | 2.14 | % | 2.29 | % | 2.02 | % | 1.87 | % | ||||||||||||
Ratio of net investment loss to average net assets
|
(0.92 | )%* | (1.30 | )% | (1.58 | )% | (1.67 | )% | (1.42 | )% | (1.58 | )% | ||||||||||||
Portfolio turnover rate
|
4 | % | 44 | % | 63 | % | 82 | % | 129 | % | 126 | % |
(1)
|
Average shares outstanding during the period are used to calculate per share data.
|
MIDAS MAGIC
|
||||||||||||||||||||||||
Six Months Ended June 30,
|
For the Year Ended December 31,
|
|||||||||||||||||||||||
2012
|
2011
|
2010
|
2009
|
2008
|
2007
|
|||||||||||||||||||
Per Share Data (for a share outstanding throughout each period)
|
||||||||||||||||||||||||
Net asset value, beginning of period
|
$ | 16.00 | $ | 14.73 | $ | 13.94 | $ | 10.36 | $ | 19.13 | $ | 16.74 | ||||||||||||
Income (loss) from investment operations:
|
||||||||||||||||||||||||
Net investment loss
(1)
|
(0.25 | ) | (0.48 | ) | (0.48 | ) | (0.37 | ) | (0.43 | ) | (0.50 | ) | ||||||||||||
Net realized and unrealized gain (loss) on investments
|
1.79 | 1.75 | 1.27 | 3.95 | (8.34 | ) | 2.89 | |||||||||||||||||
Total from investment operations
|
1.54 | 1.27 | 0.79 | 3.58 | (8.77 | ) | 2.39 | |||||||||||||||||
Net asset value, end of period
|
$ | 17.54 | $ | 16.00 | $ | 14.73 | $ | 13.94 | $ | 10.36 | $ | 19.13 | ||||||||||||
Total Return
|
9.63 | % | 8.62 | % | 5.67 | % | 34.56 | % | (45.84 | ) % | 14.28 | % | ||||||||||||
Ratios/Supplemental Data
|
||||||||||||||||||||||||
Net assets at end of period (000s omitted)
|
$ | 12,408 | $ | 11,768 | $ | 12,240 | $ | 11,582 | $ | 8,911 | $ | 17,334 | ||||||||||||
Ratio of total expenses to average net assets
|
3.90 | %* | 4.16 | % | 4.22 | % | 4.46 | % | 3.89 | % | 4.06 | % | ||||||||||||
Ratio of net expenses to average net assets
|
3.90 | %* | 4.16 | % | 4.22 | % | 4.46 | % | 3.89 | % | 4.06 | % | ||||||||||||
Ratio of net expenses excluding loan interest and fees to average net assets
|
3.68 | %* | 3.83 | % | 3.84 | % | 4.11 | % | 3.32 | % | 3.22 | % | ||||||||||||
Ratio of net investment loss to average net assets
|
(2.98 | )%* | (3.17 | )% | (3.39 | )% | (3.23 | )% | (2.71 | )% | (2.85 | )% | ||||||||||||
Portfolio turnover rate
|
4 | % | 4 | % | 0 | % | 9 | % | 13 | % | 36 | % |
·
|
Annual/Semi-Annual reports
. Includes performance data, portfolio holdings, and a letter from the Funds’ managers discussing recent market conditions, economic trends, and Fund strategies that significantly affected the Funds’ performance during the last fiscal period.
|
·
|
Statement of Additional Information (SAI)
. Provides a fuller technical and legal description of the Funds’ policies, investment restrictions, and business structure. A current SAI is on file with the SEC and is incorporated by reference (is legally considered part of this prospectus).
|
●
|
By telephone
,
call:
|
●
|
By mail, write to:
|
●
|
By e-mail, write to:
|
●
|
On the Internet, Fund documents
|
Series
|
Formerly
|
Organized as a Maryland Corporation in
|
Midas Fund
|
Midas Fund, Inc.
|
1995
|
Midas Perpetual Portfolio
|
Midas Perpetual Portfolio, Inc.
|
1974 (changed its name from Midas Dollar Reserves, Inc. on December 29, 2008)
|
Midas Magic
|
Midas Magic, Inc.
|
1986 (changed its name from Midas Special Fund, Inc. on April 29, 2011)
|
1.
|
Borrow money, except to the extent permitted by the 1940 Act;
|
2.
|
Engage in the business of underwriting the securities of other issuers, except to the extent that the Fund may be deemed to be an underwriter under the federal securities laws in connection with the disposition of the Fund’s authorized investments;
|
3.
|
Purchase or sell real estate, provided that the Fund may invest in securities (excluding limited partnership interests) secured by real estate or interests therein or issued by companies which invest in real estate or interests therein;
|
4.
|
Purchase or sell physical commodities (other than precious metals), although it may enter into (a) commodity and other futures contracts and options thereon, (b) options on commodities, including foreign currencies and precious metals, (c) forward contracts on commodities, including foreign currencies and precious metals, and (d) other financial contracts or derivative instruments;
|
5.
|
Lend its assets, provided however, that the following are not prohibited: (a) the making of time or demand deposits with banks, (b) the purchase of debt securities such as bonds, debentures, commercial paper, repurchase agreements and short term obligations in accordance with the Fund’s investment objectives and policies, and (c) engaging in securities, precious metals, and other asset loan transactions to the extent permitted by the 1940 Act;
|
6.
|
Issue senior securities as defined in the 1940 Act. The following will not be deemed to be senior securities prohibited by this provision: (a) evidences of indebtedness that the Fund is permitted to incur, (b) the issuance of additional series or classes of securities that the Board of Trustees may establish, (c) the Fund’s futures, options, and forward transactions, and (d) to the extent consistent with the 1940 Act and applicable rules and policies adopted by the Securities and Exchange Commission (“SEC”), (i) the establishment or use of a margin account with a broker for the purpose of effecting securities transactions on margin and (ii) short sales; or
|
7.
|
Purchase any securities, other than obligations of the U.S. Government or its agencies or instrumentalities, if, immediately after such purchase, more than 25% of the value of the Fund’s total assets would be invested in the securities of issuers in the same industry, except that the Fund will, under normal circumstances, invest more than 25% of the value of its total assets in securities of Natural Resources Companies.
|
1.
|
Issue senior securities as defined in the 1940 Act. The following will not be deemed to be senior securities for this purpose: (a) evidences of indebtedness that the Fund is permitted to incur, (b) the issuance of additional series or classes of securities that the Board of Trustees may establish, (c) the Fund’s futures, options, and forward currency transactions, and (d) to the extent consistent with the 1940 Act and applicable rules and policies adopted by the SEC, (i) the establishment or use of a margin account with a broker for the purpose of effecting securities transactions on margin and (ii) short sales;
|
2.
|
Lend its assets, provided however, that the following are not prohibited: (a) the making of time or demand deposits with banks, (b) the purchase of debt securities such as bonds, debentures, commercial paper, repurchase agreements and short term obligations in accordance with the Fund’s investment objective and policies and (c) engaging in securities and other asset loan transactions limited to one third of the Fund’s total assets;
|
3.
|
Underwrite the securities of other issuers, except to the extent that the Fund may be deemed to be an underwriter under the federal securities laws in connection with the disposition of the Fund’s authorized investments;
|
4.
|
Borrow money, except to the extent permitted by the 1940 Act;
|
5.
|
Purchase or sell commodities or commodity futures contracts, although it may enter into (i) financial and foreign currency futures contracts and options thereon, (ii) options on foreign currencies, and (iii) forward contracts on foreign currencies;
|
6.
|
Purchase or sell real estate, provided that the Fund may invest in securities (excluding limited partnership interests) secured by real estate or interests therein or issued by companies which invest in real estate or interests therein; or
|
7.
|
Purchase any securities, other than obligations of the U.S. Government or its agencies or instrumentalities, if, immediately after such purchase, more than 25% of the value of the Fund’s total assets would be invested in the securities of issuers in the same industry.
|
1.
|
Issue senior securities as defined in the 1940 Act. The following will not be deemed to be senior securities for this purpose: (a) evidence of indebtedness that the Fund is permitted to incur, (b) the issuance of additional series or classes of securities that the Board of Trustees may establish, (c) the Fund’s futures, options, and forward currency transactions, and (d) to the extent consistent with the 1940 Act and applicable rules and policies adopted by the SEC, (i) the establishment or use of a margin account with a broker for the purpose of effecting securities transactions on margin and (ii) short sales;
|
2.
|
Lend its assets, provided however, that the following are not prohibited: (a) the making of time or demand deposits with banks, (b) the purchase of debt securities such as bonds, debentures, commercial paper, repurchase agreements and short term obligations in accordance with the Fund’s investment objective and policies and (c) engaging in securities and other asset loan transactions limited to one third of the Fund’s total assets;
|
3.
|
Underwrite the securities of other issuers, except to the extent that the Fund may be deemed to be an underwriter under the federal securities laws in connection with the disposition of the Fund’s authorized investments;
|
4.
|
Borrow money, except to the extent permitted by the 1940 Act;
|
5.
|
Purchase or sell physical commodities (other than precious metals), although it may enter into (a) commodity and other futures contracts and options thereon, (b) options on commodities, including foreign currencies and precious metals, (c) forward contracts on commodities, including foreign currencies and precious metals, and (d) other financial contracts or derivative instruments;
|
6.
|
Purchase or sell real estate, provided that the Fund may invest in securities (excluding limited partnership interests) secured by real estate or interests therein or issued by companies which invest in real estate or interests therein; or
|
7.
|
Purchase any securities, other than obligations of the U.S. Government or its agencies or instrumentalities, if, immediately after such purchase, more than 25% of the value of the Fund’s total assets would be invested in the securities of issuers in the same industry.
|
|
For the purposes of Item 7, the Fund, notwithstanding any other investment policy or restrictions (whether or not fundamental), may, as a matter of fundamental policy, invest all of its assets in the securities or beneficial interests of a single pooled investment fund having substantially the same investment objective, policies and restrictions as the Fund.
|
|
The Board has established the following non-fundamental investment limitations that may be changed by the Board without shareholder approval:
|
1.
|
Invest up to 15% of the value of its net assets in illiquid securities, including repurchase agreements providing for settlement in more than seven days after notice;
|
2.
|
Purchase securities issued by other investment companies to the extent permitted under the 1940 Act; and
|
3.
|
Pledge, mortgage, hypothecate or otherwise encumber its assets to the extent permitted under the 1940 Act.
|
(1)
|
The value of an option position reflects, among other things, the current market price of the underlying security, securities index, commodity, or currency (each an “underlying instrument”), the time remaining until expiration, the relationship of the exercise price to the market price, the historical price volatility of the underlying instrument, and general market conditions. For this reason, the successful use of options depends upon the Investment Manager’s ability to forecast the direction of price fluctuations in the underlying securities, commodities or currency markets, or in the case of securities index options, fluctuations in the market sector represented by the selected index.
|
(2)
|
Options normally have expiration dates of up to three years. The exercise price of the options may be below, equal to or above the current market value of the underlying instrument during the term of the option. Purchased options that expire unexercised have no value. Unless an option purchased by a Fund is exercised or unless a closing transaction is effected with respect to that position, the Fund will realize a loss in the amount of the premium paid and any transaction costs.
|
(3)
|
A position in an exchange listed option may be closed out only on an exchange that provides a secondary market for identical options. Although the Funds intend to purchase or write only those exchange traded options for which there appears to be a liquid secondary market, there is no assurance that a liquid secondary market will exist for any particular option at any particular time. Closing transactions may be effected with respect to options traded in the OTC markets only by negotiating directly with the other party to the option contract or in a secondary market for the option if such market exists. Although a Fund normally will enter into OTC options with dealers that appear to be willing to enter into, and that are expected to be capable of entering into, closing transactions with a Fund, there can be no assurance that a Fund would be able to liquidate an OTC option at a favorable price at any time prior to expiration. In the event of insolvency of the counterparty to an OTC option, a Fund may be unable to liquidate an OTC option. Accordingly, it may not be possible to effect closing transactions with respect to certain options, which may result in a Fund having to exercise those options that it has purchased in order to realize any profit. With respect to options written by the Fund, the inability to enter into a closing transaction may result in material losses to a Fund. For example, because a Fund may maintain a covered position with respect to call options it writes on an instrument, it may not sell the underlying instrument (or invest any cash or securities used to cover the option) during the period it is obligated under such option. This requirement may impair a Fund’s ability to sell a portfolio security or make an investment at a time when such a sale or investment might be advantageous.
|
(4)
|
Securities index options are settled exclusively in cash. If a Fund writes a call option on an index, it cannot cover its obligation under the call index option by holding the underlying securities. In addition, a holder of a securities index option who exercises it before the closing index value for that day is available runs the risk that the level of the underlying index may subsequently change.
|
(5)
|
A Fund’s activities in the options markets may result in a higher portfolio turnover rate (which in turn may result in recognition of capital gains that will be taxable to shareholders when distributed to them) and additional brokerage costs; however, a Fund also may save on commissions by using options rather than buying or selling individual securities in anticipation or as a result of market movements.
|
(1)
|
Futures and options are highly speculative and aggressive instruments. Successful use by a Fund of futures contracts and options may depend upon the Investment Manager’s ability to predict movements in the direction of the overall securities, currencies, precious metals and interest rate markets, which requires different skills and techniques than predicting changes in the prices of individual securities. Moreover, these contracts relate not only to the current price level of the underlying instrument or currency but also to the anticipated price levels at some point in the future. There is, in addition, the risk that the movements in the price of the contract will not correlate with the movements in the prices of the securities, commodities or currencies underlying the contract or the Fund’s portfolio securities. For example, if the price of the securities index futures contract moves less than the price of the securities, the correlation will be imperfect. Further, if the price of the securities has moved in an unfavorable direction, a Fund may be in a better position than if it had not used the contract at all. If the price of the securities has moved in a favorable direction, the advantage may be partially offset by losses in the contract position. In addition, if a Fund has insufficient cash, it may have to borrow or sell assets from its portfolio to meet daily variation margin requirements. Any such sale of assets may or may not be made at prices that reflect a rising market. Consequently, a Fund may need to sell assets at a time when such sales are disadvantageous to it. If the price of the contract moves more than the price of the underlying securities, a Fund can experience either a loss or a gain on the contract that may or may not be completely offset by movements in the price of the securities.
|
(2)
|
In addition to the possibility that there may be an imperfect correlation, or no correlation at all, between price movements in the futures or options position and the underlying instruments, movements in the prices of these contracts may not correlate perfectly with movements in the prices of the securities, precious metals or currencies due to price distortions in the futures and options market. There may be several reasons unrelated to the value of the underlying instruments that cause this situation to occur. First, as noted above, all participants in the futures and options market are subject to initial and margin requirements. If, to avoid meeting additional margin deposit requirements or for other reasons, investors choose to close a significant number of futures contracts or options through offsetting transactions, distortions in the normal price relationship between the securities, precious metals, currencies and the futures and options markets may occur. Second, because the margin deposit requirements in the futures and options market are less onerous than margin requirements in the securities market, there may be increased participation by speculators in the futures market; such speculative activity in the futures market also may cause temporary price distortions. As a result, a correct forecast of general market trends may not result in successful use of futures contracts or options over the short term. In addition, activities of large traders in both the futures and securities markets involving arbitrage and other investment strategies may result in temporary price distortions.
|
(3)
|
Positions in futures contracts and options on futures may be closed out only on an exchange or board of trade that provides a secondary market for such contracts. Although a Fund intends to purchase and sell such contracts only on exchanges or boards of trade where there appears to be an active secondary market, there is no assurance that a liquid secondary market on an exchange or board of trade will exist for any particular contract at any particular time. In such event, it may not be possible to close a position, and in the event of adverse price movements, a Fund may continue to be required to make variation margin payments.
|
(4)
|
Like options on securities and currencies, options on futures contracts have limited life. The ability to establish and close out options on futures may be subject to the maintenance of liquid secondary markets on the relevant exchanges or boards of trade.
|
(5)
|
Purchasers of options on futures contracts pay a premium at the time of purchase. This amount and the transaction costs are all that is at risk. Sellers of options on futures contracts, however, must post initial margin and are subject to additional margin calls that could be substantial in the event of adverse price movements. In addition, although the maximum amount at risk when a Fund purchases an option is the premium paid for the option and the transaction costs, there may be circumstances when the purchase of an option on a futures contract may result in a loss to the Fund when the use of a futures contract may not, such as when there is no movement in the level of the underlying securities index value or the underlying securities, precious metals or currencies.
|
(6)
|
As is the case with options, a Fund’s activities in the futures and options on futures markets may result in a higher portfolio turnover rate (which in turn may result in recognition of capital gains that will be taxable to shareholders when distributed to them) and additional transaction costs in the form of added brokerage commissions; however, the Fund also may save on commissions by using futures contracts or options thereon rather than buying or selling individual securities or currencies in anticipation or as a result of market movements.
|
Name, Address, and Date of Birth
|
Trustee Since
(1)
|
Funds in Complex Overseen
|
Principal Occupation, Business Experience for Past Five Years
|
Other Directorships held by Trustee
(2)
|
Independent Trustees(
3)
:
|
||||
Bruce B. Huber, CLU, ChFC, MSFS
11 Hanover Square,
New York, NY 10005
Born February 7, 1930
|
1995 (Midas Fund)
1986 (Midas Magic)
1981 (Perpetual Portfolio)
|
6
|
Retired. He is a former Financial Representative with New England Financial, specializing in financial, estate, and insurance matters. He is a member of the Board, emeritus, of the Millbrook School, and Chairman of the Endowment Board of the Community YMCA of Red Bank, NJ.
|
None
|
James E. Hunt
11 Hanover Square
New York, NY 10005
Born December 14, 1930
|
1995 (Midas Fund)
1986 (Midas Magic)
1980 (Perpetual Portfolio)
|
6
|
Limited Partner of Hunt Howe Partners LLC, executive recruiting consultants.
|
None
|
Peter K. Werner
11 Hanover Square
New York, NY 10005
Born August 16, 1959
|
2004 (Midas Fund and Perpetual Portfolio)
2004 - July 2012 and September 2012 - Present (Midas Magic)
|
6
|
Since 1996, he has taught, directed, and coached many programs at The Governor’s Academy of Byfield, MA. Currently, he serves as chair of the History Department. Previously, he held the position of Vice President in the Fixed Income Departments of Lehman Brothers and First Boston. His responsibilities included trading sovereign debt instruments, currency arbitrage, syndication, medium term note trading, and money market trading.
|
None
|
Interested Trustee
(4)
:
|
||||
Thomas B. Winmill, Esq. Trustee, Chief Executive Officer, and President of the Trust
Born June 25, 1959
|
1995 (Midas Fund)
1997 (Midas Magic)
1993 (Perpetual Portfolio)
|
6
|
Since 1999, President of the Fund Complex and the Investment Manager and the Distributor, and of their affiliates (collectively, the “IMDA”). He is Chairman of the Investment Policy Committee (“IPC”) of the Investment Manager. He is a member of the SEC Rules Committee of the Investment Company Institute, and the New York Section member society of the American Institute of Mining, Metallurgical, and Petroleum Engineers, Inc.
|
Eagle Bulk Shipping Inc.
|
Name and Date of Birth
|
Title and Officer Since:
|
Principal Occupation, Business Experience
for Past Five Years
|
Thomas B. Winmill, Esq.
Born June 25, 1959
|
Chief Executive Officer and President since 1999.
|
See biographical information above.
|
Thomas O’Malley
Born July 22, 1958
|
Chief Accounting Officer, Chief Financial Officer, Treasurer, and Vice President since 2005.
|
Chief Accounting Officer, Chief Financial Officer, Treasurer and Vice President since 2005. He also is Chief Accounting Officer, Chief Financial Officer, Treasurer and Vice President of the Fund Complex and the IMDA. He is a certified public accountant.
|
Heidi Keating
(also known as
Irene K. Kawczynski)
Born March 28, 1959
|
Vice President since 1988.
|
Vice President since 1988. She is a member of the IPC. She is also Vice President of the Fund Complex and the IMDA.
|
John F. Ramírez, Esq.
Born April 29, 1977
|
Chief Compliance Officer, Secretary, and Vice President since 2005, and Chief Legal Officer and General Counsel since 2012.
|
CCO, VP, and Secretary since 2005, and Chief Legal Officer and General Counsel since 2012. He is also CCO, General Counsel, VP, and Secretary of the Fund Complex and Associate General Counsel of the IMDA. He is a member of the IPC. He is a member of the CCO Committee and the Compliance Advisory Committee of the Investment Company Institute.
|
Name of Trustee
|
Dollar Range
of Equity Securities in Perpetual Portfolio
|
Dollar Range
of Equity Securities in Midas Fund
|
Dollar Range of Equity Securities in Midas Magic
|
Aggregate Dollar Range of Equity Securities in All Registered Investment Companies Overseen by Trustee in Fund Complex
|
Independent Trustees:
|
||||
Bruce B. Huber
|
None
|
$1 - $10,000
|
$10,001 - $50,000
|
$10,001 - $50,000
|
James E. Hunt
|
$10,001 - $50,000
|
$10,001 - $50,000
|
$10,001 - $50,000
|
$50,001 - $100,000
|
Peter K. Werner
|
$10,001 - $50,000
|
$1- $10,000
|
$1 - $10,000
|
$10,001 - $50,000
|
Interested Trustee:
|
||||
Thomas B. Winmill
|
$1 - $10,000
|
$10,001 - $50,000
|
Over $100,000
|
Over $100,000
|
Name of Person, Position
|
Aggregate Compensation From Each Fund
|
Pension or Retirement Benefits Accrued as Part of Fund Expenses
|
Estimated Annual Benefits Upon Retirement
|
Total Compensation From Fund and Fund Complex Paid to Trustees
|
Bruce B. Huber, Trustee
|
$10,727 (Midas Fund)
$3,190 (Midas Magic)
$1,023 (Perpetual Portfolio)
|
None
|
None
|
$28,750
|
James E. Hunt, Trustee
|
$10,727 (Midas Fund)
$3,190 (Midas Magic)
$1,023 (Perpetual Portfolio)
|
None
|
None
|
$28,750
|
Peter K. Werner,
Trustee
|
$11,228 (Midas Fund)
$3,690 (Midas Magic)
$1,523 (Perpetual Portfolio)
|
None
|
None
|
$33,250
|
Affiliated Person
|
Position(s) with Funds
|
Position(s) with
Investment Manager
|
Position(s) with Distributor
|
Thomas B. Winmill
|
Trustee, CEO, and President
|
Director, CEO, President, General Counsel, Chairman IPC, Portfolio Manager
|
Director, Chairman, President, Chief Executive Officer, General Counsel, and Chief Legal Officer
|
Thomas O’Malley
|
Vice President, CFO, CAO, Treasurer
|
Director, Vice President, CFO, Treasurer
|
Director, Vice President, Treasurer, Chief Accounting Officer, and Chief Financial Officer
|
Heidi Keating
|
Vice President
|
Vice President, Member IPC
|
Vice President
|
John F. Ramírez
|
Vice President, CCO, General Counsel, Chief Legal Officer, and Secretary
|
Vice President, CCO, Associate General Counsel, Secretary, Member IPC
|
Vice President, Chief Compliance Officer, Associate General Counsel, and Secretary
|
Year
|
Fund Name
|
Amount Paid
|
Fees Waived
|
2009
|
Perpetual Portfolio
Midas Fund
Midas Magic
|
$ 0
$ 934,032
$ 99,652
|
$35,847
$0
$0
|
2010
|
Perpetual Portfolio
Midas Fund
Midas Magic
|
$ 0
$1,145,898
$ 110,504
|
$44,078
$0
$0
|
2011
|
Perpetual Portfolio
Midas Fund
Midas Magic
|
$ 0
$1,037,279
$ 111,348
|
$76,363
$0
$0
|
Year
|
Fund Name
|
Reimbursement Amount
|
2009
|
Perpetual Portfolio
Midas Fund
Midas Magic
|
$11,790
$134,384
$14,680
|
2010
|
Perpetual Portfolio
Midas Fund
Midas Magic
|
$8,599
$ 129,915
$13,000
|
2011
|
Perpetual Portfolio
Midas Fund
Midas Magic
|
$20,065
$ 125,160
$12,260
|
Name
|
Title
|
Business Experience During Past Five Years
|
Thomas B. Winmill
|
Chairman
|
See biographical information above.
|
Mark C. Winmill
|
Chief Investment Strategist
|
Executive Vice President and Director of Winco since 2000. He is President, Chief Executive Officer, and a Director of Tuxis Corporation and its subsidiaries since 2005, Vice President of Bexil Corporation since 2005, Executive Vice President of CEF Advisers, Inc. since 2012, and President, Chief Executive Officer and a Director of Global Income Fund since 2012. He is the Director of the New York Self Storage Association.
|
John F. Ramírez
|
Director of Fixed Income
|
See biographical information above.
|
Heidi Keating
|
Trading
|
See biographical information above.
|
Portfolio Managers
|
Registered Investment Companies
|
Other Pooled Investment Vehicles
|
Other Accounts
|
||||||||||
Thomas B. Winmill
|
Number:
|
2 | N/A | 2 | |||||||||
Assets (millions):
|
$ | 145 | N/A | $ | 0 | ||||||||
Bassett S. Winmill
(1)
|
Number:
|
3 | N/A | N/A | |||||||||
Assets (millions):
|
$ | 151 | N/A | N/A | |||||||||
John F. Ramírez
|
Number:
|
2 | N/A | 2 | |||||||||
Assets (millions):
|
$ | 145 | N/A | $ | 0 | ||||||||
Heidi Keating
|
Number:
|
2 | N/A | N/A | |||||||||
Assets (millions):
|
$ | 145 | N/A | N/A | |||||||||
Mark C. Winmill
(
|
Number:
|
2 | N/A | N/A | |||||||||
Assets (millions):
|
$ | 102 | N/A | N/A |
Activity
|
Perpetual Portfolio
|
Midas Fund
|
Midas Magic
|
|||||||||
Advertising
1
|
$ | 2,453 | $ | 21,458 | $ | 11,092 | ||||||
Printing and Mailing Prospectuses
2
|
$ | 7,595 | $ | 22,333 | $ | 12,702 | ||||||
Payments to the Third Parties
3
|
$ | 11,729 | $ | 79,483 | $ | 1,536 | ||||||
Compensation of Sales Personnel
4
|
$ | 14,003 | $ | 116,109 | $ | 74,839 | ||||||
Miscellaneous Expenses
5
|
$ | 2,401 | $ | 19,936 | $ | 12,812 |
·
|
the Fund shall identify before 4:00 p.m. ET of the day on which such in-kind redemptions will be required, assets held by the Fund that are available for in-kind redemption;
|
·
|
the asset price used to effect the redemption shall be the respective asset price used to calculate the net asset value of the shares being redeemed; and
|
·
|
in-kind redemptions may be limited to assets for which market quotations are readily available.
|
Year
|
Fund Name
|
Total
Amount Paid
|
2009
|
Perpetual Portfolio
Midas Fund
Midas Magic
|
$444
$ 245,447
$617
|
2010
|
Perpetual Portfolio
Midas Fund
Midas Magic
|
$176
$ 219,407
$473
|
2011
|
Perpetual Portfolio
Midas Fund
Midas Magic
|
$1,914
$ 144,589
$341
|
·
|
An auditor has a financial interest in or association with the company, and is therefore not independent;
|
·
|
There is reason to believe that the independent auditor has rendered an opinion which is neither accurate nor indicative of the company’s financial position;
|
·
|
Poor accounting practices are identified that rise to a serious level of concern, such as: fraud; misapplication of GAAP; and material weaknesses identified in Section 404 disclosures; or
|
·
|
Fees for non-audit services (“Other” fees) are excessive.
|
·
|
Non-audit (“other”) fees >audit fees + audit-related fees + tax compliance/preparation fees
|
1.1.
|
The board is classified, and a continuing director responsible for a problematic governance issue at the board/committee level that would warrant a withhold/against vote recommendation is not up for election -- any or all appropriate nominees (except new) may be held accountable;
|
1.2.
|
The board lacks accountability and oversight, coupled with sustained poor performance relative to peers. Sustained poor performance is measured by one- and three-year total shareholder returns in the bottom half of a company’s four-digit GICS industry group (Russell 3000 companies only). Take into consideration the company’s five-year total shareholder return and five-year operational metrics. Problematic provisions include but are not limited to:
|
|
·
|
A classified board structure;
|
|
·
|
A supermajority vote requirement;
|
|
·
|
Either a plurality vote standard in uncontested director elections or a majority vote standard with no plurality carve-out for contested elections;
|
|
·
|
The inability of shareholders to call special meetings;
|
|
·
|
The inability of shareholders to act by written consent;
|
|
·
|
A dual-class capital structure; and/or
|
|
·
|
A non–shareholder- approved poison pill.
|
1.3.
|
The company’s poison pill has a “dead-hand” or “modified dead-hand” feature. Vote WITHHOLD or AGAINST every year until this feature is removed;
|
1.4.
|
The board adopts a poison pill with a term of more than 12 months (“long-term pill”), or renews any existing pill, including any “short-term” pill (12 months or less), without shareholder approval. A commitment or policy that puts a newly adopted pill to a binding shareholder vote may potentially offset an adverse vote recommendation. Review such companies with classified boards every year, and such companies with annually elected boards at least once every three years, and vote AGAINST or WITHHOLD votes from all nominees if the company still maintains a non-shareholder-approved poison pill. This policy applies to all companies adopting or renewing pills after the announcement of this policy (Nov. 19, 2009); or
|
1.5.
|
The board makes a material adverse change to an existing poison pill without shareholder approval.
|
1.6.
|
The board adopts a poison pill with a term of 12 months or less (“short-term pill”) without shareholder approval, taking into account the following factors:
|
|
·
|
The date of the pill’s adoption relative to the date of the next meeting of shareholders–i.e. whether the company had time to put the pill on ballot for shareholder ratification given the circumstances;
|
|
·
|
The issuer’s rationale;
|
|
·
|
The issuer’s governance structure and practices; and
|
|
·
|
The issuer’s track record of accountability to shareholders.
|
1.7.
|
The non-audit fees paid to the auditor are excessive (see discussion under “Auditor Ratification”);
|
1.8.
|
The company receives an adverse opinion on the company’s financial statements from its auditor; or
|
1.9.
|
There is persuasive evidence that the Audit Committee entered into an inappropriate indemnification agreement with its auditor that limits the ability of the company, or its shareholders, to pursue legitimate legal recourse against the audit firm.
|
1.10.
|
Poor accounting practices are identified that rise to a level of serious concern, such as: fraud; misapplication of GAAP; and material weaknesses identified in Section 404 disclosures. Examine the severity, breadth, chronological sequence and duration, as well as the company’s efforts at remediation or corrective actions, in determining whether WITHHOLD/AGAINST votes are warranted.
|
1.11.
|
There is a significant misalignment between CEO pay and company performance (pay for performance);
|
1.14.
|
The company fails to submit one-time transfers of stock options to a shareholder vote; or
|
1.15.
|
The company fails to fulfill the terms of a burn rate commitment made to shareholders.
|
1.16.
|
The company’s previous say-on-pay proposal received the support of less than 70 percent of votes cast, taking into account:
|
|
·
|
The company’s response, including:
|
|
·
|
Disclosure of engagement efforts with major institutional investors regarding the issues that contributed to the low level of support;
|
|
·
|
Specific actions taken to address the issues that contributed to the low level of support;\
|
|
·
|
Other recent compensation actions taken by the company;
|
|
·
|
Whether the issues raised are recurring or isolated;
|
|
·
|
The company’s ownership structure; and
|
|
·
|
Whether the support level was less than 50 percent, which would warrant the highest degree of responsiveness.
|
1.17.
|
Material failures of governance, stewardship, risk oversight, or fiduciary responsibilities at the company;
|
1.18.
|
Failure to replace management as appropriate; or
|
1.19.
|
Egregious actions related to a director’s service on other boards that raise substantial doubt about his or her ability to effectively oversee management and serve the best interests of shareholders at any company.
|
2.1.
|
The board failed to act on a shareholder proposal that received the support of a majority of the shares outstanding the previous year;
|
2.2.
|
The board failed to act on a shareholder proposal that received the support of a majority of shares cast in the last year and one of the two previous years;
|
2.3.
|
The board failed to act on takeover offers where the majority of shares are tendered;
|
2.4.
|
At the previous board election, any director received more than 50 percent withhold/against votes of the shares cast and the company has failed to address the issue(s) that caused the high withhold/against vote; or
|
2.5.
|
The board implements an advisory vote on executive compensation on a less frequent basis than the frequency that received the majority of votes cast at the most recent shareholder meeting at which shareholders voted on the say-on-pay frequency.
|
2.6.
|
The board implements an advisory vote on executive compensation on a less frequent basis than the frequency that received a plurality, but not a majority, of the votes cast at the most recent shareholder meeting at which shareholders voted on the say-on-pay frequency, taking into account:
|
|
·
|
The board’s rationale for selecting a frequency that is different from the frequency that received a plurality;
|
|
·
|
The company’s ownership structure and vote results;
|
|
·
|
ISS’ analysis of whether there are compensation concerns or a history of problematic compensation practices; and
|
|
·
|
The previous year’s support level on the company’s say-on-pay proposal.
|
3.1.
|
The inside or affiliated outside director serves on any of the three key committees: audit, compensation, or nominating;
|
3.2.
|
The company lacks an audit, compensation, or nominating committee so that the full board functions as that committee;
|
3.3.
|
The company lacks a formal nominating committee, even if the board attests that the independent directors fulfill the functions of such a committee; or
|
3.4.
|
Independent directors make up less than a majority of the directors.
|
4.1.
|
The company’s proxy indicates that not all directors attended 75 percent of the aggregate board and committee meetings, but fails to provide the required disclosure of the names of the director(s) involved.
|
4.2.
|
Attend less than 75 percent of the board and committee meetings (with the exception of new nominees). Acceptable reasons for director absences are generally limited to the following:
|
|
·
|
Medical issues/illness;
|
|
·
|
Family emergencies; and
|
|
·
|
Missing only one meeting.
|
4.3.
|
Sit on more than six public company boards; or
|
4.4.
|
Are CEOs of public companies who sit on the boards of more than two public companies besides their own– withhold only at their outside boards.
|
|
·
|
Long-term financial performance of the target company relative to its industry;
|
|
·
|
Management’s track record;
|
|
·
|
Background to the proxy contest;
|
|
·
|
Qualifications of director nominees (both slates);
|
|
·
|
Strategic plan of dissident slate and quality of critique against management;
|
|
·
|
Likelihood that the proposed goals and objectives can be achieved (both slates);
|
|
·
|
Stock ownership positions.
|
|
·
|
Company-specific factors; and
|
|
·
|
Proposal-specific factors, including:
|
|
·
|
The ownership thresholds proposed in the resolution (i.e., percentage and duration);
|
|
·
|
The maximum proportion of directors that shareholders may nominate each year; and
|
|
·
|
The method of determining which nominations should appear on the ballot if multiple shareholders submit nominations.
|
|
·
|
Whether the company has been materially harmed by shareholder litigation outside its jurisdiction of incorporation, based on disclosure in the company’s proxy statement; and
|
|
·
|
Whether the company has the following good governance features:
|
|
·
|
An annually elected board;
|
|
·
|
A majority vote standard in uncontested director elections; and
|
|
·
|
The absence of a poison pill, unless the pill was approved by shareholders.
|
|
·
|
No lower than a 20% trigger, flip-in or flip-over;
|
|
·
|
A term of no more than three years;
|
|
·
|
No dead-hand, slow-hand, no-hand or similar feature that limits the ability of a future board to redeem the pill;
|
|
·
|
Shareholder redemption feature (qualifying offer clause); if the board refuses to redeem the pill 90 days after a qualifying offer is announced, 10 percent of the shares may call a special meeting or seek a written consent to vote on rescinding the pill.
|
|
·
|
The ownership threshold to transfer (NOL pills generally have a trigger slightly below 5 percent);
|
|
·
|
The value of the NOLs;
|
|
·
|
Shareholder protection mechanisms (sunset provision, or commitment to cause expiration of the pill upon exhaustion or expiration of NOLs);
|
|
·
|
The company’s existing governance structure including: board independence, existing takeover defenses, track record of responsiveness to shareholders, and any other problematic governance concerns; and
|
|
·
|
Any other factors that may be applicable.
|
|
·
|
Shareholders’ current right to act by written consent;
|
|
·
|
The consent threshold;
|
|
·
|
The inclusion of exclusionary or prohibitive language;
|
|
·
|
Investor ownership structure; and
|
|
·
|
Shareholder support of, and management’s response to, previous shareholder proposals.
|
|
·
|
An unfettered right for shareholders to call special meetings at a 10 percent threshold;
|
|
·
|
A majority vote standard in uncontested director elections;
|
|
·
|
No non-shareholder-approved pill; and
|
|
·
|
An annually elected board.
|
|
·
|
Past Board Performance:
|
|
·
|
The company’s use of authorized shares during the last three years
|
|
·
|
The Current Request:
|
|
·
|
Disclosure in the proxy statement of the specific purposes of the proposed increase;
|
|
·
|
Disclosure in the proxy statement of specific and severe risks to shareholders of not approving the request; and
|
|
·
|
The dilutive impact of the request as determined by an allowable increase calculated by ISS (typically 100 percent of existing authorized shares) that reflects the company’s need for shares and total shareholder returns.
|
|
·
|
Past Board Performance:
|
|
·
|
The company’s use of authorized preferred shares during the last three years;
|
|
·
|
The Current Request:
|
|
·
|
Disclosure in the proxy statement of the specific purposes for the proposed increase;
|
|
·
|
Disclosure in the proxy statement of specific and severe risks to shareholders of not approving the request;
|
|
·
|
In cases where the company has existing authorized preferred stock, the dilutive impact of the request as determined by an allowable increase calculated by ISS (typically 100 percent of existing authorized shares) reflects the company’s need for shares and total shareholder returns; and
|
|
·
|
Whether the shares requested are blank check preferred shares that can be used for antitakeover purposes.
|
|
·
|
The company discloses a compelling rationale for the dual-class capital structure, such as:
|
|
·
|
The company’s auditor has concluded that there is substantial doubt about the company’s ability to continue as a going concern; or
|
|
·
|
The new class of shares will be transitory;
|
|
·
|
The new class is intended for financing purposes with minimal or no dilution to current shareholders in both the short term and long term; and
|
|
·
|
The new class is not designed to preserve or increase the voting power of an insider or significant shareholder.
|
|
·
|
Valuation
- Is the value to be received by the target shareholders (or paid by the acquirer) reasonable? While the fairness opinion may provide an initial starting point for assessing valuation reasonableness, emphasis is placed on the offer premium, market reaction and strategic rationale.
|
|
·
|
Market reaction
- How has the market responded to the proposed deal? A negative market reaction should cause closer scrutiny of a deal.
|
|
·
|
Strategic rationale
- Does the deal make sense strategically? From where is the value derived? Cost and revenue synergies should not be overly aggressive or optimistic, but reasonably achievable. Management should also have a favorable track record of successful integration of historical acquisitions.
|
|
·
|
Negotiations and process
- Were the terms of the transaction negotiated at arm’s-length? Was the process fair and equitable? A fair process helps to ensure the best price for shareholders. Significant negotiation “wins” can also signify the deal makers’ competency. The comprehensiveness of the sales process (e.g., full auction, partial auction, no auction) can also affect shareholder value.
|
|
·
|
Conflicts of interest
- Are insiders benefiting from the transaction disproportionately and inappropriately as compared to non-insider shareholders? As the result of potential conflicts, the directors and officers of the company may be more likely to vote to approve a merger than if they did not hold these interests. Consider whether these interests may have influenced these directors and officers to support or recommend the merger. The CIC figure presented in the “ISS Transaction Summary” section of this report is an aggregate figure that can in certain cases be a misleading indicator of the true value transfer from shareholders to insiders. Where such figure appears to be excessive, analyze the underlying assumptions to determine whether a potential conflict exists.
|
|
·
|
Governance
- Will the combined company have a better or worse governance profile than the current governance profiles of the respective parties to the transaction? If the governance profile is to change for the worse, the burden is on the company to prove that other issues (such as valuation) outweigh any deterioration in governance.
|
|
·
|
There is a significant misalignment between CEO pay and company performance (pay for performance);
|
|
·
|
The company maintains significant problematic pay practices;
|
|
·
|
The board exhibits a significant level of poor communication and responsiveness to shareholders.
|
|
·
|
There is no MSOP on the ballot, and an AGAINST vote on an MSOP is warranted due to pay for performance misalignment, problematic pay practices, or the lack of adequate responsiveness on compensation issues raised previously, or a combination thereof;
|
|
·
|
The board fails to respond adequately to a previous MSOP proposal that received less than 70 percent support of votes cast;
|
|
·
|
The company has recently practiced or approved problematic pay practices, including option repricing or option backdating; or
|
|
·
|
The situation is egregious.
|
|
·
|
A pay for performance misalignment is found, and a significant portion of the CEO’s misaligned pay is attributed to non-performance-based equity awards, taking into consideration:
|
|
·
|
Magnitude of pay misalignment;
|
|
·
|
Contribution of non-performance-based equity grants to overall pay; and
|
|
·
|
The proportion of equity awards granted in the last three fiscal years concentrated at the named executive officer (NEO) level.
|
|
·
|
The degree of alignment between the company’s TSR rank and the CEO’s total pay rank within a peer group, as measured over one-year and three-year periods (weighted 40/60);
|
|
·
|
The multiple of the CEO’s total pay relative to the peer group median.
|
|
·
|
The ratio of performance- to time-based equity awards;
|
|
·
|
The ratio of performance-based compensation to overall compensation;
|
|
·
|
The completeness of disclosure and rigor of performance goals;
|
|
·
|
The company’s peer group benchmarking practices;
|
|
·
|
Actual results of financial/operational metrics, such as growth in revenue, profit, cash flow, etc., both absolute and relative to peers;
|
|
·
|
Special circumstances related to, for example, a new CEO in the prior fiscal year or anomalous equity grant practices (e.g., biennial awards); and
|
|
·
|
Any other factors deemed relevant.
|
|
·
|
Problematic practices related to non-performance-based compensation elements;
|
|
·
|
Incentives that may motivate excessive risk-taking; and
|
|
·
|
Options Backdating.
|
|
·
|
Repricing or replacing of underwater stock options/SARS without prior shareholder approval (including cash buyouts and voluntary surrender of underwater options);
|
|
·
|
Excessive perquisites or tax gross-ups, including any gross-up related to a secular trust or restricted stock vesting;
|
|
·
|
New or extended agreements that provide for:
|
|
·
|
CIC payments exceeding 3 times base salary and average/target/most recent bonus;
|
|
·
|
CIC severance payments without involuntary job loss or substantial diminution of duties (“single” or “modified single” triggers);
|
|
·
|
CIC payments with excise tax gross-ups (including “modified” gross-ups).
|
|
·
|
Multi-year guaranteed bonuses;
|
|
·
|
A single or common performance metric used for short- and long-term plans;
|
|
·
|
Lucrative severance packages;
|
|
·
|
High pay opportunities relative to industry peers;
|
|
·
|
Disproportionate supplemental pensions; or
|
|
·
|
Mega annual equity grants that provide unlimited upside with no downside risk.
|
|
·
|
Reason and motive for the options backdating issue, such as inadvertent vs. deliberate grant date changes;
|
|
·
|
Duration of options backdating;
|
|
·
|
Size of restatement due to options backdating;
|
|
·
|
Corrective actions taken by the board or compensation committee, such as canceling or re-pricing backdated options, the recouping of option gains on backdated grants; and
|
|
·
|
Adoption of a grant policy that prohibits backdating, and creates a fixed grant schedule or window period for equity grants in the future.
|
|
·
|
Failure to respond to majority-supported shareholder proposals on executive pay topics; or
|
|
·
|
Failure to adequately respond to the company’s previous say-on-pay proposal that received the support of less than 70 percent of votes cast, taking into account:
|
|
·
|
The company’s response, including:
|
|
·
|
Disclosure of engagement efforts with major institutional investors regarding the issues that contributed to the low level of support;
|
|
·
|
Specific actions taken to address the issues that contributed to the low level of support;
|
|
·
|
Other recent compensation actions taken by the company;
|
|
·
|
Whether the issues raised are recurring or isolated;
|
|
·
|
The company’s ownership structure; and
|
|
·
|
Whether the support level was less than 50 percent, which would warrant the highest degree of responsiveness.
|
|
·
|
Recently adopted or materially amended agreements that include excise tax gross-up provisions (since prior annual meeting);
|
|
·
|
Recently adopted or materially amended agreements that include modified single triggers (since prior annual meeting);
|
|
·
|
Single trigger payments that will happen immediately upon a change in control, including cash payment and such items as the acceleration of performance-based equity despite the failure to achieve performance measures;
|
|
·
|
Single-trigger vesting of equity based on a definition of change in control that requires only shareholder approval of the transaction (rather than consummation);
|
|
·
|
Potentially excessive severance payments;
|
|
·
|
Recent amendments or other changes that may make packages so attractive as to influence merger agreements that may not be in the best interests of shareholders;
|
|
·
|
In the case of a substantial gross-up from pre-existing/grandfathered contract: the element that triggered the gross-up (i.e., option mega-grants at low point in stock price, unusual or outsized payments in cash or equity made or negotiated prior to the merger); or
|
|
·
|
The company’s assertion that a proposed transaction is conditioned on shareholder approval of the golden parachute advisory vote. ISS would view this as problematic from a corporate governance perspective.
|
|
·
|
The total cost of the company’s equity plans is unreasonable;
|
|
·
|
The plan expressly permits repricing;
|
|
·
|
A pay-for-performance misalignment is found;
|
|
·
|
The company’s three year burn rate exceeds the burn rate cap of its industry group;
|
|
·
|
The plan has a liberal change-of-control definition; or
|
|
·
|
The plan is a vehicle for problematic pay practices.
|
|
·
|
Whether adoption of the proposal is likely to enhance or protect shareholder value;
|
|
·
|
Whether the information requested concerns business issues that relate to a meaningful percentage of the company’s business as measured by sales, assets, and earnings;
|
|
·
|
The degree to which the company’s stated position on the issues raised in the proposal could affect its reputation or sales, or leave it vulnerable to a boycott or selective purchasing;
|
|
·
|
Whether the issues presented are more appropriately/effectively dealt with through governmental or company-specific action;
|
|
·
|
Whether the company has already responded in some appropriate manner to the request embodied in the proposal;
|
|
·
|
Whether the company’s analysis and voting recommendation to shareholders are persuasive;
|
|
·
|
What other companies have done in response to the issue addressed in the proposal;
|
|
·
|
Whether the proposal itself is well framed and the cost of preparing the report is reasonable;
|
|
·
|
Whether implementation of the proposal’s request would achieve the proposal’s objectives;
|
|
·
|
Whether the subject of the proposal is best left to the discretion of the board;
|
|
·
|
Whether the requested information is available to shareholders either from the company or from a publicly available source; and
|
|
·
|
Whether providing this information would reveal proprietary or confidential information that would place the company at a competitive disadvantage.
|
|
·
|
There are no recent, significant controversies, fines or litigation regarding the company’s political contributions or trade association spending; and
|
|
·
|
The company has procedures in place to ensure that employee contributions to company-sponsored political action committees (PACs) are strictly voluntary and prohibit coercion.
|
|
·
|
The company’s current disclosure of policies and oversight mechanisms related to its direct political contributions and payments to trade associations or other groups that may be used for political purposes, including information on the types of organizations supported and the business rationale for supporting these organizations; and
|
|
·
|
Recent significant controversies, fines, or litigation related to the company’s political contributions or political activities.
|
|
·
|
The company’s current disclosure of relevant policies and oversight mechanisms;
|
|
·
|
Recent significant controversies, fines, or litigation related to the company’s public policy activities; and
|
|
·
|
The impact that the policy issues may have on the company’s business operations.
|
|
·
|
The company’s current level of disclosure of relevant policies and oversight mechanisms;
|
|
·
|
The company’s current level of such disclosure relative to its industry peers;
|
|
·
|
Potential relevant local, state, or national regulatory developments; and
|
|
·
|
Controversies, fines, or litigation related to the company’s hydraulic fracturing operations.
|
(a)
|
Trust Instrument. (6)
|
(b)
|
Bylaws. (6)
|
(c)
|
See Article VI, “Shareholders’ Voting Powers and Meetings” of Registrant’s Trust Instrument.
|
|
See Article II, “Shareholders” of Registrant’s Bylaws.
|
(d)
|
Investment Management Agreement. (6)
|
(e)
|
Distribution Agreement between the Registrant and Midas Securities Group, Inc. (6)
|
(f)
|
Not applicable.
|
(g)
|
(i)
|
Form of Custodian Agreement with State Street Bank and Trust Company. (2)
|
|
(ii)
|
Supplement to Custodian Agreement. (3)
|
|
(iii)
|
Amendment to Custodian Agreement. (6)
|
(h)
|
(i)
|
Mutual Fund Services Agreement. (5)
|
|
(ii)
|
Consent to Assignment of Mutual Fund Services Agreement. (6)
|
|
(iii)
|
Lending Agreement. (5)
|
|
(iv)
|
Consent to Assignment of Lending Agreement for Midas Fund. (6)
|
|
(v)
|
Consent to Assignment of Lending Agreement for Midas Magic. (6)
|
|
(vi)
|
Consent to Assignment of Lending Agreement for Midas Perpetual Portfolio. (6)
|
|
(vii)
|
Committed Facility Agreement. (5)
|
|
(viii)
|
Consent to Assignment of Committed Facility Agreement. (6)
|
|
(ix)
|
Special Custody and Pledge Agreement. (5)
|
|
(x)
|
Consent to Assignment of Special Custody and Pledge Agreement for Midas Fund. (6)
|
|
(xi)
|
Consent to Assignment of Special Custody and Pledge Agreement for Midas Magic. (6)
|
|
(xii)
|
Consent to Assignment of Special Custody and Pledge Agreement for Midas Perpetual Portfolio.
(6)
|
(i)
|
Opinion and Consent of Counsel as to Legality of Securities Being Registered. (6)
|
(j)
|
Accountant’s Consent. (6)
|
(k)
|
Not applicable.
|
(l)
|
Agreement for providing initial capital. (1)
|
|
(m)
|
Plan of Distribution. (6)
|
|
(n)
|
Not applicable.
|
|
(o)
|
Reserved.
|
|
(p)
|
Code of Ethics. (4)
|
|
(1)
|
Incorporated herein by reference to the corresponding exhibit to Post-Effective Amendment No. 26 to the registration statement of the Registrant, SEC file number 2-98229, filed on March 1, 2000.
|
|
(2)
|
Incorporated herein by reference to the corresponding exhibit to Post-Effective Amendment No. 29 to the registration statement of the Registrant, SEC file number 2-98229, filed on April 22, 2002.
|
|
(3)
|
Incorporated herein by reference to the corresponding exhibits to Post-Effective Amendment No. 28 to the registration statement of the Registrant, SEC file number 2-98229, filed on May 1, 2001.
|
|
(4)
|
Incorporated herein by reference to the corresponding exhibit to Post-Effective Amendment No. 39 to the registration statement of the Registrant, SEC file number 2-98229, filed on December 15, 2008.
|
|
(5)
|
Incorporated herein by reference to the corresponding exhibit to the Post-Effective Amendment No. 48 to the registration statement of the Registrant, SEC file number 2-98229, filed on April 30, 2012.
|
|
(6)
|
Filed herewith.
|
a)
|
Midas Securities does not serve as principal underwriter to any investment company other than the Registrant.
|
b)
|
Midas Securities serves as the Registrant’s principal underwriter. The directors and officers of Midas Securities, their principal business addresses, their positions and offices with Midas Securities and their positions and offices with the Registrant (if any) are set forth below.
|
Name and Principal
Business Address
|
Position and Offices with
Midas Securities Group, Inc.
|
Position and Offices with Registrant
|
Thomas B. Winmill
11 Hanover Square
New York, NY 10005
|
Director, Chairman, President, Chief Executive Officer, General Counsel, Chief Legal Officer, Control Person
|
Trustee, Chairman, President, and Chief Executive Officer
|
Mark C. Winmill
11 Hanover Square
New York, NY 10005
|
Control Person
|
None
|
Thomas O’Malley
11 Hanover Square
New York, NY 10005
|
Director, Vice President, Treasurer, Chief Accounting Officer, and Chief Financial Officer
|
Vice President, Treasurer, Chief Accounting Officer, Chief Financial Officer
|
John F. Ramírez, Esq.
11 Hanover Square
New York, NY 10005
|
Vice President, Chief Compliance Officer, Associate General Counsel, and Secretary
|
Vice President, Chief Compliance Officer, Chief Legal Officer, General Counsel, and Secretary
|
/s/ Thomas B. Winmill
|
Chairman, Trustee, President, and
|
October 11, 2012
|
|
Thomas B. Winmill
|
Chief Executive Officer
|
||
/s/ Thomas O’Malley
|
Treasurer, Chief Accounting Officer,
|
October 11, 2012
|
|
Thomas O’Malley
|
Chief Financial Officer
|
||
/s/ Bruce B. Huber*
|
Trustee
|
October 11, 2012
|
|
Bruce B. Huber
|
|||
/s/ James E. Hunt*
|
Trustee
|
October 11, 2012
|
|
James E. Hunt
|
|||
/s/ Peter K. Werner*
|
Trustee
|
October 11, 2012
|
|
Peter K. Werner
|
|||
MIDAS SERIES TRUST | |
By: /s/ Bruce B. Huber | |
Name: Bruce B. Huber | |
Title: Trustee | |
By: /s/ James E. Hunt | |
Name: James E. Hunt | |
Title: Trustee | |
By: /s/ Peter K. Werner | |
Name: Peter K. Werner | |
Title: Trustee | |
Exhibit
|
|
28(a)
|
Trust Instrument.
|
28(b)
|
Bylaws.
|
28(d)
|
Investment Management Agreement.
|
28(e)
|
Distribution Agreement between Registrant and Midas Securities Group, Inc.
|
28(g)(iii)
|
Amendment to Custodian Agreement.
|
28(h)(ii)
|
Consent to Assignment of Mutual Fund Services Agreement.
|
28(h)(iv)
|
Consent to Assignment of Lending Agreement for Midas Fund.
|
28(h)(v)
|
Consent to Assignment of Lending Agreement for Midas Magic.
|
28(h)(vi)
|
Consent to Assignment of Lending Agreement for Midas Perpetual Portfolio.
|
28(h)(viii)
|
Consent to Assignment of Committed Facility Agreement.
|
28(h)(x)
|
Consent to Assignment of Special Custody and Pledge Agreement for Midas Fund.
|
28(h)(xi)
|
Consent to Assignment of Special Custody and Pledge Agreement for Midas Magic.
|
28(h)(xii)
|
Consent to Assignment of Special Custody and Pledge Agreement for Midas Perpetual Portfolio.
|
28(i)
|
Opinion and Consent of Counsel as to Legality of Securities Being Registered.
|
28(j)
|
Accountant’s Consent.
|
28(m)
|
Plan of Distribution.
|
ARTICLE I | DEFINITIONS | 1 |
ARTICLE II | THE TRUSTEES | 2 |
Section 1.
|
MANAGEMENT OF THE TRUST.
|
2 |
Section 2.
|
ELECTION AND NUMBER OF TRUSTEES.
|
3 |
Section 3.
|
TERM OF OFFICE OF TRUSTEES.
|
3 |
Section 4.
|
VACANCIES; APPOINTMENT OF TRUSTEES.
|
3 |
Section 5.
|
TEMPORARY VACANCY OR ABSENCE.
|
3 |
Section 6.
|
CHAIRMAN.
|
3 |
Section 7.
|
ACTION BY THE TRUSTEES.
|
4 |
Section 8.
|
OWNERSHIP OF TRUST PROPERTY.
|
4 |
Section 9.
|
EFFECT OF TRUSTEES NOT SERVING.
|
4 |
Section 10.
|
TRUSTEES AND OTHERS AS SHAREHOLDERS.
|
4 |
ARTICLE III | POWERS OF THE TRUSTEES | 4 |
Section 1.
|
POWERS.
|
4 |
Section 2.
|
CERTAIN TRANSACTIONS.
|
8 |
ARTICLE IV | SERIES; CLASSES; SHARES | 8 |
Section 1.
|
ESTABLISHMENT OF SERIES AND CLASSES.
|
8 |
Section 2.
|
SHARES.
|
8 |
Section 3.
|
9 | |
Section 4.
|
ASSETS AND LIABILITIES OF SERIES AND CLASSES.
|
9 |
Section 5.
|
OWNERSHIP AND TRANSFER OF SHARES.
|
10 |
Section 6.
|
11 | |
ARTICLE V | DISTRIBUTIONS, REDEMPTIONS AND NET ASSET VALUE | 11 |
Section 1.
|
11 | |
Section 2.
|
12 | |
Section 3.
|
12 | |
Section 4.
|
SUSPENSION OF RIGHT OF REDEMPTION.
|
13 |
ARTICLE VI | SHAREHOLDERS’ VOTING POWERS AND MEETINGS | 13 |
Section 1.
|
13 | |
Section 2.
|
13 | |
Section 3.
|
14 | |
ARTICLE VI | CONTRACTS WITH SERVICE PROVIDERS | 14 |
Section 1.
|
14 | |
Section 2.
|
14 | |
Section 3.
|
14 | |
Section 4.
|
15 | |
Section 5.
|
15 | |
ARTICLE VIII | EXPENSES OF THE TRUST, SERIES AND CLASSES | 15 |
ARTICLE IX | LIMITATION OF LIABILITY AND INDEMNIFICATION | 15 |
Section 1.
|
15 | |
Section 2.
|
16 | |
Section 3.
|
17 | |
ARTICLE X | MISCELLANEOUS | 17 |
Section 1.
|
17 |
Section 2.
|
17 | |
Section 3.
|
17 | |
Section 4.
|
19 | |
Section 5.
|
19 | |
Section 6.
|
19 | |
Section 7.
|
FISCAL
YEAR.
|
20 |
Section 8.
|
20 | |
Section 9.
|
20 |
ARTICLE I | PRINCIPAL OFFICE AND SEAL | 1 | |
Section 1.01. | Principal Office. | 1 | |
Section 1.02. | Delaware Office. | 1 | |
Section 1.03. | Seal. | 1 | |
ARTICLE II | SHAREHOLDERS | 1 | |
Section 2.01. | Annual Meetings. | 1 | |
Section 2.02. | Special Meetings. | 1 | |
Section 2.03. | Notice of Meetings. | 2 | |
Section 2.04. | Adjournment . | 2 | |
Section 2.05. | Voting – Proxies. | 2 | |
Section 2.06. | Concerning Validity of Proxies, Ballots, Etc. | 3 | |
Section 2.07. | Organization . | 3 | |
Section 2.08. | Record Date . | 4 | |
Section 2.09. | Action Without Meeting. | 4 | |
ARTICLE III | BOARD OF TRUSTEES | 4 | |
Section 3.01. | Number and Term of Office . | 4 | |
Section 3.02. | General Powers. | 4 | |
Section 3.03. | Regular Meetings. | 4 | |
Section 3.04. | Special Meetings. | 4 | |
Section 3.05. | Meetings by Telephone. | 5 | |
Section 3.06. | Notice . | 5 | |
Section 3.07. | Waiver of Notice. | 5 | |
Section 3.08. | Quorum and Voting. | 5 | |
Section 3.09. | Compensation . | 5 | |
Section 3.10. | Action Without a Meeting. | 5 | |
ARTICLE IV |
COMMITTEES
|
5 | |
Section 4.01. | Establishment . | 6 | |
Section 4.02. | Proceedings , Quorum and Manner of Acting. | 6 | |
ARTICLE V | BOARD CHAIRMAN AND TRUST OFFICERS | 7 | |
Section 5.01. | General . | 7 | |
Section 5.02. | Election , Term of Office and Qualifications. | 7 | |
Section 5.03. | Resignation . | 7 | |
Section 5.04. | Removal . | 7 | |
Section 5.05. | Vacancies and Newly Created Offices. | 7 | |
Section 5.06. | Powers . | 7 | |
Section 5.07. | Subordinate Officers. | 8 | |
Section 5.08. | Remuneration . | 8 | |
Section 5 .09. | Surety Bond. | 8 | |
ARTICLE VI | EXECUTION OF INSTRUMENTS, VOTING OF SECURITIES | 8 | |
Section 6.01. | General . | 8 | |
Section 6.02. | Checks, Notes , Drafts, Etc. | 8 | |
Section 6 . 03. | Voting of Securities . | 8 | |
ARTICLE VII | SHARES OF BENEFICIAL INTEREST | 9 | |
Section 7 . 01. | No Share Certificates. | 9 |
Section 7.02. | Register . | 9 | |
Section 7. 03 . | Transfer of Shares. | 9 | |
ARTICLE VIII | MISCELLANEOUS | 9 | |
Section 8. 01 . | Inspection of Records and Reports. | 9 | |
Section 8.02 . | Waiver of Notice. | 9 | |
Section 8. 03 . | Severability | 10 | |
Section 8.04 . | Headings . | 10 | |
ARTICLE IX | AMENDMENTS | 10 |
1.
|
Each Series hereby employs the Investment Manager to manage the investment and reinvestment of its assets, including the regular furnishing of advice with respect to each Series’ portfolio transactions subject at all times to the control and oversight of the Trust’s Board of Trustees (the “Investment Advisory Services”), for the period and on the terms set forth in this Agreement. The Investment Manager hereby accepts such employment and agrees during such period to render the Investment Advisory Services and, if requested, any other services contemplated herein and to assume the obligations herein set forth, for the compensation herein provided. The Investment Manager shall for all purposes herein be deemed to be an independent contractor and shall, unless otherwise expressly provided or authorized, have no authority to act for or represent the Trust or the Series in any way, or otherwise be deemed an agent of the Trust or the Series.
|
2.
|
Each Series assumes and shall pay all the expenses required for the conduct of its business including, but not limited to:
|
a.
|
fees of the Investment Manager;
|
b.
|
fees and commissions in connection with the purchase and sale of portfolio securities for the Series;
|
c.
|
costs, including the interest expense, of borrowing money;
|
d.
|
fees and premiums for the fidelity bond required by Section 17(g) of the 1940 Act, or other insurance;
|
e.
|
taxes levied against the Series and the expenses of preparing tax returns and reports;
|
f.
|
auditing fees and expenses;
|
g.
|
legal fees and expenses (including reasonable fees for legal services rendered to the Series by the Investment Manager or its affiliates);
|
h.
|
salaries and other compensation of (1) any of the Trust’s officers and employees who are not officers, trustees, stockholders or employees of the Investment Manager or any of its affiliates, and (2) the Trust’s chief compliance officer to the extent determined by those trustees of the Trust who are not interested persons of the Investment Manager or its affiliates (the “Independent Trustees”);
|
i.
|
fees and expenses incidental to trustee and shareholder meetings of the Trust or the Series, the preparation and mailings of proxy material, prospectuses, and reports of the Series to its shareholders, the filing of reports with regulatory bodies, and the maintenance of the Trust’s legal existence;
|
j.
|
costs of the registration of shares of the Series with Federal and state securities authorities (and maintenance of such registration);
|
k.
|
payment of dividends;
|
l.
|
costs of share certificates;
|
m.
|
fees and expenses of the Independent Trustees;
|
n.
|
fees and expenses for accounting, administration, bookkeeping, broker/dealer record keeping, clerical, compliance, custody, dividend disbursing, reports providing and fulfillment of requests for Series information, proxy soliciting, securities pricing, registrar, and transfer agent services (including costs and out-of-pocket expenses payable to the Investment Manager or its affiliates for such services);
|
o.
|
costs of necessary office space rental and Trust/Series web site development and maintenance;
|
p.
|
costs of membership dues and charges of investment company industry trade associations;
|
q.
|
such non-recurring expenses as may arise, including, without limitation, actions, suits or proceedings affecting the Trust and the Series and the legal obligation which the Trust or the Series may have to indemnify its officers and trustees or settlements made; and
|
r.
|
any and all organizational expenses of the Trust or a Series paid by the Investment Manager, which shall be reimbursed by the Trust at such time or times agreed to by the Trust and/or such Series and the Investment Manager.
|
3.
|
The Investment Manager shall supply the Series and the Board of Trustees with reports and statistical data, as reasonably requested. In addition, if requested by the Trust’s Board of Trustees, the Investment Manager or its affiliates may provide services to the Trust or Series such as, without limitation, accounting, administration, bookkeeping, broker/dealer record keeping, clerical, compliance, custody, dividend disbursing, fulfillment of requests for Series information, proxy soliciting, securities pricing, registrar, and transfer agent services. Any reports, statistical data, and services so requested, or approved by the Board of Trustees, and supplied or performed will be for the account of the applicable Series and the costs and out-of-pocket charges of the Investment Manager and its affiliates in providing such reports, statistical data or services shall be paid by that Series, subject to periodic reporting to and examination by the Independent Trustees.
|
4.
|
The Investment Manager may, but shall not be obligated to, pay or provide for the payment of expenses which are primarily intended to result in the sale of the Series’ shares or the servicing and maintenance of shareholder accounts, including, without limitation, payments for: advertising, direct mail and promotional expenses; compensation and expenses, including overhead and telephone and other communication expenses, of the Investment Manager and its affiliates, the Series, and selected dealers and their affiliates who engage in or support the distribution of shares or who service shareholder accounts; fulfillment expenses including the costs of printing and distributing prospectuses, statements of additional information, and reports for other than existing shareholders; the costs of preparing, printing and distributing sales literature and advertising materials; and internal costs incurred by the Investment Manager and its affiliates and allocated to efforts to distribute shares of the Series such as office rent and equipment, employee salaries, employee bonuses and other overhead expenses. Such payments may be for the Investment Manager’s own account or may be made on behalf of a Series pursuant to a written agreement relating to a plan of distribution of the Series pursuant to Rule 12b-1 under the 1940 Act.
|
5.
|
The services of the Investment Manager are not to be deemed exclusive, and the Investment Manager shall be free to render similar services to others in addition to the Trust and the Series so long as its services hereunder are not impaired thereby.
|
6.
|
The Investment Manager shall create and maintain all necessary books and records in accordance with all applicable laws, rules and regulations, including but not limited to records required by Section 31(a) of the 1940 Act and the rules thereunder, as the same may be amended from time to time, pertaining to the Investment Advisory Services and other services, if any, performed by it hereunder and not otherwise created and maintained by another party pursuant to a written contract with the Trust. Where applicable, such records shall be maintained by the Investment Manager for the periods and in the places required by Rule 31a-2 under the 1940 Act. The books and records pertaining to a Series which are in the possession of the Investment Manager shall be the property of the Series and shall be surrendered promptly upon the Series’ request, and the Series shall have access to such books and records at all times during the Investment Manager’s normal business hours. Upon the reasonable request of the Series, copies of any such books and records shall be promptly provided by the Investment Manager to the Series or the Series’ authorized representatives. The Investment Manager shall keep confidential any information obtained in connection with its duties hereunder; provided, however, if the Series has authorized and directed certain disclosure or if such disclosure is expressly required or lawfully requested by applicable Federal or state regulatory authorities or otherwise, the Series shall reimburse the Investment Manager for its expenses in connection therewith, including the reasonable fees and expenses of the Investment Manager’s outside legal counsel.
|
7.
|
For the Investment Advisory Services provided to the Series pursuant to this Agreement, each Series will pay to the Investment Manager, and the Investment Manager will accept as full compensation therefor, an annual fee as set out in Schedule B to this Agreement. The management fee shall accrue on each calendar day, and shall be payable monthly on or before the tenth (10th) day of each calendar month. The daily fee accruals shall be computed by multiplying the fraction of one divided by the number of days in the calendar year by the applicable annual management fee rate (as set forth in Schedule B hereto) and multiplying this product by the net assets of the Series, determined in the manner established by the Board of Trustees, as of the close of business on the last preceding business day on which the Series’ net asset value was determined. Such fees shall be reduced as required by expense limitations imposed upon the Series by any state in which shares of the Series are sold. Reductions shall be made at the time of each monthly payment on an estimated basis, if appropriate, and an adjustment to reflect the reduction on an annual basis shall be made, if necessary, in the fee payable with respect to the last month in any calendar year of the Series. The Investment Manager shall within ten (10) days after the end of each calendar year refund any amount paid in excess of the fee determined to be due for such year.
|
|
If this Agreement shall become effective subsequent to the first day of a month, or shall terminate before the last day of a month, the Investment Manager’s compensation for such fraction of the month shall be determined by applying the applicable annual management fee rate (as set forth in Schedule B hereto), to the Series’ net assets during such fraction of a month (calculated on an average daily basis if such fraction of a month is less than a week) and in the proportion that such fraction of a month bears to the entire month.
|
8.
|
The Investment Manager shall direct portfolio transactions to broker/dealers for execution on terms and at rates which it believes, in good faith, to be reasonable in view of the overall nature and quality of services provided by a particular broker/dealer, including brokerage and research services. Subject to the foregoing and applicable laws, rules and regulations, the Investment Manager may also allocate portfolio transactions to broker/dealers that remit a portion of their commissions as a credit against Series expenses. With respect to brokerage and research services, the Investment Manager may consider in the selection of broker/dealers brokerage or research provided and payment may be made of a fee higher than that charged by another broker/dealer which does not furnish brokerage or research services or which furnishes brokerage or research services deemed to be of lesser value, so long as the criteria of Section 28(e) of the Securities Exchange Act of 1934, as amended, or other applicable laws are met. Although the Investment Manager may direct portfolio transactions without necessarily obtaining the lowest price at which such broker/dealer, or another, may be willing to do business, the Investment Manager shall seek the best value for the Series on each trade that circumstances in the marketplace permit, including the value inherent in ongoing relationships with quality brokers. To the extent any such brokerage or research services may be deemed to be additional compensation to the Investment Manager from the Series, it is authorized by this Agreement. The Investment Manager may place brokerage for the Series through an affiliate of the Investment Manager, provided that such brokerage be undertaken in compliance with applicable law. The Investment Manager’s fees under this Agreement shall not be reduced by reason of any commissions, fees or other remuneration received by such affiliate from the Series.
|
9.
|
Subject to and in accordance with the Certificate of Trust or similar document (the “Charter”), Trust Instrument or Articles of Incorporation and Bylaws of the Trust and of the Investment Manager, it is understood that trustees, officers, agents and shareholders of the Trust are or may be interested in the Trust as trustees, officers, shareholders and otherwise, that the Investment Manager is or may be interested in the Trust as a shareholder or otherwise and that the effect and nature of any such interests shall be governed by law and by the provisions, if any, of said Charter, Trust Instrument or Articles of Incorporation, or Bylaws.
|
10.
|
This Agreement shall become effective upon the date hereinabove written with respect to each Series listed in Schedule A on that date and, unless sooner terminated as provided herein, this Agreement shall continue in effect for two years from the above written date. With respect to each Series added by the execution of an Addendum to Schedule A, the term of this Agreement shall begin on the date of such execution and, unless sooner terminated as provided herein, this Agreement shall remain in effect for two years following the date of execution. Thereafter, in each case, this Agreement shall continue in effect with respect to each Series automatically for successive periods of twelve months each, subject to the termination provisions and all other terms and conditions hereof, provided that such continuance with respect to a Series is specifically approved at least annually (a) by a vote of a majority of the Trustees of the Trust or by vote of the holders of a majority of the Series’ outstanding voting securities, as defined in the 1940 Act, and (b) by a vote of a majority of the Trustees of the Trust who are not parties to this Agreement, or interested persons of such parties. This Agreement may be terminated without penalty at any time either by vote of the Board of Trustees of the Trust or by a vote of the holders of a majority of the outstanding voting securities of the Series on 60 days’ written notice to the Investment Manager, or by the Investment Manager on 60 days’ written notice to the Series. Termination of this Agreement with respect to any given Series shall in no way affect the continued validity of this Agreement or the performance thereunder with respect to any other Series. This Agreement shall immediately terminate in the event of its assignment.
|
11.
|
The Investment Manager shall not be liable to the Series or any shareholder of the Series for any error of judgment or mistake of law or for any loss suffered by the Series or the Series’ shareholders in connection with the matters to which this Agreement relates, but nothing herein contained shall be construed to protect the Investment Manager against any liability to the Series or the Series’ shareholders by reason of a loss resulting from willful misfeasance, bad faith, or gross negligence in the performance of its duties or by reason of its reckless disregard of obligations and duties under this Agreement.
|
12.
|
The Investment Manager shall not be liable for delays or errors occurring by reason of circumstances beyond its control, including but not limited to acts of civil or military authority, national emergencies, work stoppages, fire, flood, catastrophe, acts of God, insurrection, war, riot, or failure of communication or power supply. In the event of equipment breakdowns beyond its control, the Investment Manager shall take reasonable steps to minimize service interruptions but shall have no liability with respect thereto. Notwithstanding anything herein to the contrary, the Investment Manager shall have in place at all times a reasonable disaster recovery plan and program.
|
13.
|
As used in this Agreement, the terms “interested person,” “assignment,” and “majority of the outstanding voting securities” shall have the meanings provided therefor in the 1940 Act, and the rules and regulations thereunder.
|
14.
|
This Agreement shall be construed in accordance with and governed by the laws of the State of Delaware, provided, however, that nothing herein shall be construed in a manner inconsistent with the 1940 Act or any rule or regulation promulgated thereunder.
|
15.
|
This Agreement constitutes the entire agreement between the parties hereto and supersedes any prior agreement, with respect to the subject hereof, whether oral or written. If any provision of this Agreement shall be held or made invalid by a court or regulatory agency, decision, statute, rule or otherwise, the remainder of this Agreement shall not be affected thereby. This Agreement may be amended at any time, but only by written agreement between the Investment Manager and the Trust or Series, which amendment has been authorized by the Board, including the vote of a majority of the Independent Trustees and, where required by the 1940 Act, the shareholders of the Series.
|
Series
|
Rate of Compensation Based on Average Daily Net Assets
|
Midas Magic Fund
|
1.00% of net assets up to $10 million
0.875% of net assets over $10 million up to $30 million
0.75% of net assets over $30 million up to $150 million
0.625% of net assets over $150 million up to $500 million
0.50% of net assets over $500 million
|
Midas Fund
|
1.00% of net assets up to $200 million
0.95% of net assets over $200 million up to $400 million
0.90% of net assets over $400 million up to $600 million
0.85% of net assets over $600 million up to $800 million
0.80% of net assets over $800 million up to $1 billion
0.75% of net assets over $1 billion
|
Midas Perpetual Portfolio
|
0.50% of net assets up to $250 million
0.45% of net assets from $250 million to $500 million.
0.40% of net assets over $500 million
|
MIDAS SERIES TRUST
|
|
ATTEST:
|
|
Jacob Bukhsbaum | By: /s/ John F. Ramírez |
MIDAS SECURITIES GROUP, INC.
|
|
ATTEST:
|
|
Jacob Bukhsbaum | By: /s/ John F. Ramírez |
1.
|
Amendment and Restatement of Exhibit A
. Exhibit A to the Agreement is amended and restated in the form attached hereto, to provide for the addition to the Agreement of Midas Series Trust, a Delaware statutory trust, and the removal from the Agreement of Midas Perpetual Portfolio, Inc., Midas Fund, Inc., and Midas Magic, Inc., each a Maryland corporation.
|
2.
|
General Provisions
. This Amendment may be executed in any number of counterparts, each constituting an original and all considered one and the same agreement. This Amendment is intended to modify and amend the Agreement and the terms of this Amendment and the Agreement are to be construed to be cumulative and not exclusive of each other. Except as provided herein, the Agreement is hereby ratified and confirmed and remains in full force and effect.
|
STATE STREET BANK AND TRUST COMPANY |
EACH REGISTERED INVESTMENT COMPANY LISTED ON EXHIBIT A
|
By:
/s/ Bruce Donnelly
|
By: /s/ John F. Ramírez |
Name: Bruce Donnelly | Name: John F. Ramírez |
Title:
Vice President
|
Title: General Counsel |
HUNTINGTON ASSET SERVICES, INC.
|
|
By:
/s/
Matthew J. Miller
|
|
Name:
Matthew J. Miller
|
|
Title:
Vice President
|
|
MIDAS FUND, INC.
|
|
By:
/s/ John F. Ramírez
|
|
Name:
John F. Ramírez
|
|
Title:
Vice President
|
|
MIDAS MAGIC, INC.
|
|
By:
/s/ John F. Ramírez
|
|
Name:
John F. Ramírez
|
|
Title:
Vice President
|
|
MIDAS PERPETUAL PORTFOLIO, INC.
|
|
By:
/s/ John F. Ramírez
|
|
Name:
John F. Ramírez
|
|
Title:
Vice President
|
BNP PARIBAS, ACTING THROUGH ITS NEW YORK BRANCH
|
|
By:
/s/ M. Andrews Yeo
|
|
Name:
M. Andrews Yeo
|
|
Title:
Managing Director
|
|
By:
/s/ Christopher J. Innes
|
|
Name:
Christopher J. Innes
|
|
Title:
Managing Director
|
|
MIDAS FUND, INC.
|
|
By:
/s/ John F. Ramírez
|
|
Name:
John F. Ramírez
|
|
Title:
Vice President
|
BNP PARIBAS, ACTING THROUGH ITS NEW YORK BRANCH
|
|
By:
/s/ M. Andrews Yeo
|
|
Name:
M. Andrews Yeo
|
|
Title:
Managing Director
|
|
By:
/s/ Christopher J. Innes
|
|
Name:
Christopher J. Innes
|
|
Title:
Managing Director
|
|
MIDAS MAGIC, INC.
|
|
By:
/s/ John F. Ramírez
|
|
Name:
John F. Ramírez
|
|
Title: Vice President |
BNP PARIBAS, ACTING THROUGH ITS NEW YORK BRANCH
|
|
By:
/s/ M. Andrews Yeo
|
|
Name:
M. Andrews Yeo
|
|
Title:
Managing Director
|
|
By:
/s/ Christopher J. Innes
|
|
Name:
Christopher J. Innes
|
|
Title:
Managing Director
|
|
MIDAS PERPETUAL PORTFOLIO, INC.
|
|
By:
/s/ John F. Ramírez
|
|
Name:
John F. Ramírez
|
|
Title:
Vice President
|
BNP PARIBAS, ACTING THROUGH ITS NEW YORK BRANCH
|
|
By:
/s/ M. Andrews Yeo
|
|
Name:
M. Andrews Yeo
|
|
Title:
Managing Director
|
|
By:
/s/ Christopher J. Innes
|
|
Name:
Christopher J. Innes
|
|
Title:
Managing Director
|
|
MIDAS FUND, INC.
|
|
By:
/s/ John F. Ramírez
|
|
Name:
John F. Ramírez
|
|
Title:
Vice President
|
STATE STREET BANK AND TRUST COMPANY
|
|
By:
/s/ Bruce Donnelly
|
|
Name:
Bruce Donnelly
|
|
Title:
Vice President
|
|
BNP PARIBAS, ACTING THROUGH ITS NEW YORK BRANCH
|
|
By:
/s/ M. Andrews Yeo
|
|
Name:
M. Andrews Yeo
|
|
Title:
Managing Director
|
|
By:
/s/ Christopher J. Innes
|
|
Name:
Christopher J. Innes
|
|
Title:
Managing Director
|
|
MIDAS FUND, INC.
|
|
By:
/s/ John F. Ramírez
|
|
Name:
John F. Ramírez
|
|
Title:
Vice President
|
STATE STREET BANK AND TRUST COMPANY
|
|
By:
/s/ Bruce Donnelly
|
|
Name:
Bruce Donnelly
|
|
Title:
Vice President
|
|
BNP PARIBAS, ACTING THROUGH ITS NEW YORK BRANCH
|
|
By:
/s/ M. Andrews Yeo
|
|
Name:
M. Andrews Yeo
|
|
Title:
Managing Director
|
|
By:
/s/ Christopher J. Innes
|
|
Name:
Christopher J. Innes
|
|
Title:
Managing Director
|
|
MIDAS MAGIC, INC.
|
|
By:
/s/ John F. Ramírez
|
|
Name:
John F. Ramírez
|
|
Title:
Vice President
|
STATE STREET BANK AND TRUST COMPANY
|
|
By:
/s/ Bruce Donnelly
|
|
Name:
Bruce Donnelly
|
|
Title:
Vice President
|
|
BNP PARIBAS, ACTING THROUGH ITS NEW YORK BRANCH
|
|
By:
/s/ M. Andrews Yeo
|
|
Name:
M. Andrews Yeo
|
|
Title:
Managing Director
|
|
By:
/s/ Christopher J. Innes
|
|
Name:
Christopher J. Innes
|
|
Title:
Managing Director
|
|
MIDAS PERPETUAL PORTFOLIO, INC.
|
|
By:
/s/ John F. Ramírez
|
|
Name:
John F. Ramírez
|
|
Title:
Vice President
|
Midas Series Trust
11 Hanover Square
New York, NY 10005-3452
|
Very truly yours,
|
|
/s/ K&L Gates LLP
|
|
|
TAIT, WELLER & BAKER LLP
|
ATTEST:
|
MIDAS SERIES TRUST
|
|
By:
/s/
Jacob Bukhsbaum
|
By:
/s/
John F. Ramírez
|